Markets:

Overview

News

Currencies

International

Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.13 +0.19 (+1.74%)

Streaming Delayed Price Updated: 1:29 PM EDT, May 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum

October 02, 2025

From AngioDynamics, Inc.

Via Business Wire

Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus ↗

October 02, 2025

U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed.

Via Benzinga

Topics Stocks

S&P 500 Closes At Record High: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗

October 02, 2025

CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with record S&P 500 level.

Via Benzinga

Topics Stocks

Earnings Scheduled For October 2, 2025 ↗

October 02, 2025

Via Benzinga

What's Next: AngioDynamics's Earnings Preview ↗

October 01, 2025

Via Benzinga

Earnings Outlook For AngioDynamics ↗

July 14, 2025

Via Benzinga

AngioDynamics, Globant And 3 Stocks To Watch Heading Into Thursday ↗

October 02, 2025

US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics.

Via Benzinga

Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings ↗

October 01, 2025

Via Benzinga

AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025

September 18, 2025

From AngioDynamics, Inc.

Via Business Wire

Recent Report Shows That Rep. Debbie Wasserman Schultz Bought Up to $15K Worth of Ichor Holdings Stock ↗

August 07, 2025

Via Benzinga

AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference

August 06, 2025

From AngioDynamics, Inc.

Via Business Wire

A Congress Member Sold Up To $30K In AngioDynamics Stock: Here's What You Need To Know ↗

July 28, 2025

Via Benzinga

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

July 28, 2025

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology

July 23, 2025

From AngioDynamics, Inc.

Via Business Wire

Why AngioDynamics Stock Popped, Then Dropped Today ↗

July 15, 2025

AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed.

Via The Motley Fool

Topics Earnings

AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting ↗

July 15, 2025

AngioDynamics expects a $4 million-$6 million impact from tariffs. Still, it's "profitable," CEO Jim Clemmer says.

Via Benzinga

Topics World Trade

AngioDynamics (ANGO) Q4 2025 Earnings Transcript ↗

July 15, 2025

Via The Motley Fool

Topics World Trade

AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth

July 15, 2025

From AngioDynamics, Inc.

Via Business Wire

Earnings Scheduled For July 15, 2025 ↗

July 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 14, 2025

Via Benzinga

Get insights into the top gainers and losers of Monday's after-hours session. ↗

July 14, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025

July 07, 2025

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism

June 23, 2025

From AngioDynamics, Inc.

Via Business Wire

Gold Moves Higher; US Private Sector Job Growth Tops Estimates ↗

April 02, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

April 02, 2025

In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance ↗

April 02, 2025

AngioDynamics raised its fiscal 2025 sales outlook to $285M-$288M and boosted its adjusted EBITDA forecast, expecting stronger Med Tech revenue growth.

Via Benzinga

These stocks are moving in today's pre-market session ↗

April 02, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday ↗

April 02, 2025

Via Benzinga

AngioDynamics Stock Rockets On Upbeat Q3, Improved Full-Year Guidance – But Retail Sentiment Plummets ↗

April 02, 2025

The medical technology company now expects net sales to be $285 to $288 million for the fiscal year 2025, up from previously issued guidance of $282 to $288 million, owing to increased medical...

Via Stocktwits

AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results

April 02, 2025

From AngioDynamics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

All News about AngioDynamics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today